HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Perols Selected Research

Neoplasms (Cancer)

1/2018Molecular design of radiocopper-labelled Affibody molecules.
1/2017Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA.
3/2016Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
1/2014Position for site-specific attachment of a DOTA chelator to synthetic affibody molecules has a different influence on the targeting properties of 68Ga- compared to 111in-labeled conjugates.
1/2013Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.
8/2012Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules.
5/2012Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA.
5/2011Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Perols Research Topics

Disease

8Neoplasms (Cancer)
01/2018 - 05/2011
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2017
2Prostatic Neoplasms (Prostate Cancer)
03/2012 - 05/2011
1Neoplasm Metastasis (Metastasis)
01/2017

Drug/Important Bio-Agent (IBA)

61,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2014 - 05/2011
51- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
01/2018 - 03/2012
41,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2017 - 05/2011
4Radioisotopes (Radionuclides)IBA
03/2016 - 05/2011
2Chelating AgentsIBA
08/2012 - 03/2012
1Cys-ZHER2-342 affibodyIBA
01/2018
1AndrogensIBA
03/2012
1ErbB Receptors (EGF Receptor)IBA
03/2012

Therapy/Procedure

4Therapeutics
01/2018 - 05/2011